BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

4:50 PM
 | 
Mar 10, 2010
 |  BC Extra  |  Company News

Cellzome, GSK in inflammatory deal

Cellzome AG (Heidelberg, Germany) and GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) will use Cellzome's Episphere technology to discover small molecules against undisclosed epigenetic targets to treat inflammatory diseases. Cellzome...

Read the full 122 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >